Upgrade to SI Premium - Free Trial

Juno Therapeutics (JUNO) Shares to Reflect 'Increased Level of Uncertainty' - Leerink

November 23, 2016 12:50 PM
Leerink Partners analyst Michael Schmidt weighed in on Juno Therapeutics (NASDAQ: JUNO) after the company announced that it placed the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments FDA

Next Articles